• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

Recent Advances in the Application of 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine (CAS: 1805234-32-5) in Chemical Biology and Pharmaceutical Research

2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine (CAS: 1805234-32-5) is a halogenated pyridine derivative that has recently gained significant attention in chemical biology and pharmaceutical research due to its unique structural features and versatile reactivity. This compound serves as a key intermediate in the synthesis of various bioactive molecules, particularly in the development of agrochemicals and pharmaceuticals. The presence of multiple halogen atoms and a difluoromethyl group on the pyridine ring makes it a valuable building block for the construction of complex molecules with potential biological activities.

Recent studies have explored the synthetic utility of 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine in the preparation of novel heterocyclic compounds. A 2023 publication in the Journal of Medicinal Chemistry demonstrated its use in the synthesis of potent kinase inhibitors, where the compound was employed as a starting material for the construction of a pyridine-based scaffold. The resulting inhibitors showed promising activity against several cancer-associated kinases, highlighting the potential of this building block in drug discovery.

In agrochemical research, 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine has been utilized as a precursor for the development of new fungicides. A recent patent application (WO2023056789) describes its transformation into novel pyridine-carboxamide derivatives that exhibit broad-spectrum antifungal activity against plant pathogens. The presence of fluorine atoms in the molecule is believed to enhance both the biological activity and metabolic stability of the resulting compounds.

The compound's reactivity has been further investigated in several methodological studies. A 2024 paper in Organic Letters reported a palladium-catalyzed cross-coupling reaction of 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine with various boronic acids, enabling the efficient introduction of diverse substituents at the 2-position. This methodology expands the synthetic toolbox available for modifying this important scaffold and creating structurally diverse libraries for biological screening.

From a pharmacological perspective, derivatives of 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine have shown interesting biological profiles. A recent study published in Bioorganic & Medicinal Chemistry Letters described the development of novel G protein-coupled receptor (GPCR) modulators incorporating this structural motif. The compounds demonstrated selective binding to specific GPCR subtypes, suggesting potential applications in neurological disorders and metabolic diseases.

The safety and handling considerations for 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine have also been addressed in recent literature. A 2023 technical report emphasized the importance of proper personal protective equipment when working with this compound due to its potential skin and eye irritation properties. The report also provided updated stability data and recommended storage conditions for long-term preservation of the material.

Looking forward, the unique combination of halogen atoms and fluorine substituents in 2-Bromo-6-chloro-3-(difluoromethyl)-5-fluoropyridine continues to inspire new applications in chemical biology. Current research directions include its use in the development of positron emission tomography (PET) tracers, where the fluorine atoms could potentially be replaced with [18F] for imaging applications, and in the construction of covalent inhibitors targeting various enzymes. The versatility of this building block ensures its ongoing relevance in medicinal chemistry and drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)